241 related articles for article (PubMed ID: 27241521)
1. Protective efficacy and safety of liver stage attenuated malaria parasites.
Kumar H; Sattler JM; Singer M; Heiss K; Reinig M; Hammerschmidt-Kamper C; Heussler V; Mueller AK; Frischknecht F
Sci Rep; 2016 May; 6():26824. PubMed ID: 27241521
[TBL] [Abstract][Full Text] [Related]
2. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
3. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine.
Nagel A; Prado M; Heitmann A; Tartz S; Jacobs T; Deschermeier C; Helm S; Stanway R; Heussler V
Int J Parasitol; 2013 May; 43(6):503-14. PubMed ID: 23500072
[TBL] [Abstract][Full Text] [Related]
4. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.
Jobe O; Lumsden J; Mueller AK; Williams J; Silva-Rivera H; Kappe SH; Schwenk RJ; Matuschewski K; Krzych U
J Infect Dis; 2007 Aug; 196(4):599-607. PubMed ID: 17624847
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
6. Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.
van der Velden M; Rijpma SR; Verweij V; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Franke-Fayard BM; Russel FG; Janse CJ; Sauerwein RW; Koenderink JB
Am J Trop Med Hyg; 2016 Aug; 95(2):378-82. PubMed ID: 27296385
[TBL] [Abstract][Full Text] [Related]
7. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
8. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.
Mueller AK; Deckert M; Heiss K; Goetz K; Matuschewski K; Schlüter D
Am J Pathol; 2007 Jul; 171(1):107-15. PubMed ID: 17591958
[TBL] [Abstract][Full Text] [Related]
9. Addition of histamine to subcutaneously injected Plasmodium berghei sporozoites increases the parasite liver load and could facilitate whole-parasite vaccination.
Pfeil J; Heine JF; Mueller AK
Malar J; 2015 Jan; 14():36. PubMed ID: 25627880
[TBL] [Abstract][Full Text] [Related]
10. A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice.
Vaughan AM; Sack BK; Dankwa D; Minkah N; Nguyen T; Cardamone H; Kappe SHI
Infect Immun; 2018 May; 86(5):. PubMed ID: 29440367
[TBL] [Abstract][Full Text] [Related]
11. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM
Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550
[TBL] [Abstract][Full Text] [Related]
12. Immunization efficacy of cryopreserved genetically attenuated Plasmodium berghei sporozoites.
Prinz H; Sattler JM; Roth A; Ripp J; Adams JH; Frischknecht F
Parasitol Res; 2018 Aug; 117(8):2487-2497. PubMed ID: 29797085
[TBL] [Abstract][Full Text] [Related]
13. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.
Jaijyan DK; Singh H; Singh AP
J Biol Chem; 2015 Aug; 290(32):19496-511. PubMed ID: 25960542
[TBL] [Abstract][Full Text] [Related]
14. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
Nganou-Makamdop K; Ploemen I; Behet M; Van Gemert GJ; Hermsen C; Roestenberg M; Sauerwein RW
Parasite Immunol; 2012 Dec; 34(12):562-9. PubMed ID: 23171040
[TBL] [Abstract][Full Text] [Related]
15. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine.
Kreutzfeld O; Müller K; Matuschewski K
Front Cell Infect Microbiol; 2017; 7():198. PubMed ID: 28620583
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.
Mueller AK; Camargo N; Kaiser K; Andorfer C; Frevert U; Matuschewski K; Kappe SH
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3022-7. PubMed ID: 15699336
[TBL] [Abstract][Full Text] [Related]
17. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites.
Butler NS; Schmidt NW; Vaughan AM; Aly AS; Kappe SH; Harty JT
Cell Host Microbe; 2011 Jun; 9(6):451-62. PubMed ID: 21669394
[TBL] [Abstract][Full Text] [Related]
18. Signatures of malaria vaccine efficacy in ageing murine immune memory.
Haussig JM; Burgold J; Hafalla JC; Matuschewski K; Kooij TW
Parasite Immunol; 2014 May; 36(5):199-206. PubMed ID: 24495208
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Liver-Stage Biology of Malaria Parasites: Insights to Enable and Accelerate the Development of a Highly Efficacious Vaccine.
Mo AX; McGugan G
Am J Trop Med Hyg; 2018 Oct; 99(4):827-832. PubMed ID: 30141395
[TBL] [Abstract][Full Text] [Related]
20. Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses.
Doll KL; Pewe LL; Kurup SP; Harty JT
J Immunol; 2016 May; 196(10):4253-62. PubMed ID: 27084099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
